Accession Number: | 0001104659-20-029756 |
Date: | 2020-03-04 |
Issuer: | IMMUNOMEDICS INC (IMMU) |
Original Submission Date: |
MALIK USAMA
C/O IMMUNOMEDICS, INC.
300 THE AMERICAN ROAD
MORRIS PLAINS, NJ 07950
Title of Security | Transaction Date | 2a. Deemed Execution Date | Transaction Code | Shares | Acquired or Disposed | Price per share | 5. Amount of Securities Beneficially Owned Following Reported Transaction | 6. Ownership Form Direct or Indirect | Nature of Indirect Ownership |
---|
Title of Derivative Security | Conversion or Exercise Price of Derivative Security | Transaction Date | Deemed Execution Date | Transaction Code | Number of Derivative Securities Acquired (A) or Disposed of (D) | Date Exercisable | Expiration Date | Title and Amount of Securities Underlying Derivative Security | Price of Derivative Security | Number of derivative Securities Beneficially Owned Following Reported Transaction(s) | Ownership Form: Direct (D) or Indirect (I) | Nature of Indirect Beneficial Ownership |
---|---|---|---|---|---|---|---|---|---|---|---|---|
STOCK OPTION (RIGHT TO BUY) | 17.16 | 2020-03-04 | deemed execution date | A | 61,920 (a) | 2027-03-04 | common stock, par value $0.01 per share 61,920 | $17.16 | 61,920 | direct |
ID | footnote |
---|---|
f1 | the reporting person was granted stock options pursuant to the issuer's 2014 long-term incentive plan (the "plan"). the stock options vest 25% on the first anniversary of the date of grant, and on a quarterly basis thereafter over a three year period. |